Segall Bryant & Hamill, LLC Cocrystal Pharma, Inc. Transaction History

Segall Bryant & Hamill, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$0.7 - $1.58 $9,100 - $20,540	-13,000 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$0.48 - $2.19 $720 - $3,285	-1,500 Reduced 10.34%	13,000 $9,000
Q4 2019 Feb 11, 2020	SELL	$0.39 - $2.05 $624 - $3,279	-1,600 Reduced 9.94%	14,500 $7,000
Q3 2019 Nov 12, 2019	SELL	$1.69 - $2.88 $1,500 - $2,557	-888 Reduced 5.23%	16,100 $33,000
Q2 2019 Aug 14, 2019	BUY	$2.06 - $2.75 $1,487 - $1,985	722 Added 4.44%	16,988 $0
Q1 2019 May 15, 2019	BUY	$2.65 - $4.14 $11,241 - $17,561	4,242 Added 35.28%	16,266 $0
Q4 2018 Feb 15, 2019	BUY	$1.6 - $3.68 $838 - $1,928	524 Added 4.56%	12,024 $43,000
Q3 2018 Nov 14, 2018	SELL	$2.3 - $4.95 $2,300 - $4,950	-1,000 Reduced 8.0%	11,500 $0
Q2 2018 Aug 08, 2018	BUY	$1.79 - $6.25 $22,375 - $78,125	12,500 New	12,500 $0

Ticker COCP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,122,420
Market Cap $14.6M
Description
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company ...

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.